BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30291913)

  • 21. Genomic analysis of metastatic cutaneous squamous cell carcinoma.
    Li YY; Hanna GJ; Laga AC; Haddad RI; Lorch JH; Hammerman PS
    Clin Cancer Res; 2015 Mar; 21(6):1447-56. PubMed ID: 25589618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma.
    Chahoud J; Gleber-Netto FO; McCormick BZ; Rao P; Lu X; Guo M; Morgan MB; Chu RA; Martinez-Ferrer M; Eterovic AK; Pickering CR; Pettaway CA
    Clin Cancer Res; 2021 May; 27(9):2560-2570. PubMed ID: 33441293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous metastasis from penile squamous cell carcinoma resembling carcinoma en cuirasse.
    Brady KL; Scott GA; Gilmore ES
    Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding genomics and the immune environment of penile cancer to improve therapy.
    Aydin AM; Chahoud J; Adashek JJ; Azizi M; Magliocco A; Ross JS; Necchi A; Spiess PE
    Nat Rev Urol; 2020 Oct; 17(10):555-570. PubMed ID: 32812000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights into the Molecular Profile of Penile Squamous Cell Carcinoma.
    McGregor BA; Sonpavde GP
    Clin Cancer Res; 2021 May; 27(9):2375-2377. PubMed ID: 33653819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
    Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
    Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome.
    Hartz JM; Engelmann D; Fürst K; Marquardt S; Spitschak A; Goody D; Protzel C; Hakenberg OW; Pützer BM
    J Urol; 2016 Aug; 196(2):570-8. PubMed ID: 26896570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study.
    Necchi A; Lo Vullo S; Perrone F; Raggi D; Giannatempo P; Calareso G; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Togliardi E; Colecchia M; Busico A; Gloghini A; Testi A; Mariani L; Salvioni R
    BJU Int; 2018 Mar; 121(3):348-356. PubMed ID: 28921872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.
    Ferrandiz-Pulido C; Masferrer E; Toll A; Hernandez-Losa J; Mojal S; Pujol RM; Ramon y Cajal S; de Torres I; Garcia-Patos V
    J Urol; 2013 Dec; 190(6):2288-95. PubMed ID: 23764082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.
    Ribera-Cortada I; Guerrero-Pineda J; Trias I; Veloza L; Garcia A; Marimon L; Diaz-Mercedes S; Alamo JR; Rodrigo-Calvo MT; Vega N; López Del Campo R; Parra-Medina R; Ajami T; Martínez A; Reig O; Ribal MJ; Corral-Molina JM; Jares P; Ordi J; Rakislova N
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets.
    Ashford BG; Clark J; Gupta R; Iyer NG; Yu B; Ranson M
    Head Neck; 2017 Jul; 39(7):1462-1469. PubMed ID: 28370784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma.
    Mueller SA; Gauthier MA; Ashford B; Gupta R; Gayevskiy V; Ch'ng S; Palme CE; Shannon K; Clark JR; Ranson M; Cowley MJ
    J Invest Dermatol; 2019 Jul; 139(7):1449-1458.e1. PubMed ID: 30684551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.
    Ross JS; Sokol ES; Moch H; Mileshkin L; Baciarello G; Losa F; Beringer A; Thomas M; Elvin JA; Ngo N; Jin DX; Krämer A
    Oncologist; 2021 Mar; 26(3):e394-e402. PubMed ID: 33219618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
    Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
    J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational landscape of penile squamous cell carcinoma in a Chinese population.
    Wang Y; Wang K; Chen Y; Zhou J; Liang Y; Yang X; Li X; Cao Y; Wang D; Luo L; Li B; Li D; Wang L; Liang Z; Gao C; Wang Q; Lv Q; Li Z; Shi Y; Niu H
    Int J Cancer; 2019 Sep; 145(5):1280-1289. PubMed ID: 31034097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression.
    Leis PF; Stevens KR; Baer SC; Kadmon D; Goldberg LH; Wang XJ
    Cancer; 1998 Jul; 83(1):122-9. PubMed ID: 9655301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets.
    Lobl MB; Clarey D; Higgins S; Sutton A; Hansen L; Wysong A
    J Dermatol Sci; 2020 Jul; 99(1):30-43. PubMed ID: 32595073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets.
    Yang ES; Willey CD; Mehta A; Crowley MR; Crossman DK; Chen D; Anderson JC; Naik G; Della Manna DL; Cooper TS; Sonpavde G
    Oncotarget; 2017 Mar; 8(13):21710-21718. PubMed ID: 28423512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.